Is the Epstein–Barr virus EBNA-1 protein an oncogen?
- 17 February 2009
- journal article
- editorial
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 106 (7), 2091-2092
- https://doi.org/10.1073/pnas.0812575106
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- The Epstein–Barr virus nuclear antigen-1 promotes genomic instability via induction of reactive oxygen speciesProceedings of the National Academy of Sciences, 2009
- HLA class I polymorphisms are associated with development of infectious mononucleosis upon primary EBV infectionJCI Insight, 2007
- Epstein–Barr virus promotes genomic instability in Burkitt's lymphomaOncogene, 2007
- Three restricted forms of Epstein–Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cellsProceedings of the National Academy of Sciences, 2006
- Epstein–Barr virus: 40 years onNature Reviews Cancer, 2004
- bcl-xL and RAG genes are induced and the response to IL-2 enhanced in EμEBNA-1 transgenic mouse lymphocytesOncogene, 2002
- An Epstein-Barr virus-specific cytotoxic T cell epitope in EBV nuclear antigen 3 (EBNA 3).The Journal of Experimental Medicine, 1990
- Genetic analysis of immortalizing functions of Epstein–Barr virus in human B lymphocytesNature, 1989
- Transformation of foetal human leukocytes in vitro by filtrates of a human leukaemic cell line containing herpes‐like virusInternational Journal of Cancer, 1968
- VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMAThe Lancet, 1964